Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0344307 (
analgesia
)
28,200
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of Captopril (SQ 14,225) were studied in mice both by measuring the reaction time and observing the number of jumping mice in the 'hot-plate' test. Subcutaneous injections of captopril (0.1--0.4 mg/kg) produced a significant increase in the reaction time at the 4th hour after the injection while no difference in the reaction time was observed at other times. Captopril caused a clear-cut increase in the number of jumping mice which was found to be greater with lower doses of the compound. Morphine alone did not cause an increase in the number of jumping mice, but increased the reaction time which reached a maximum 1 h after administration and gradually returned to the control level after 6 h. Injection of morphine to the captopril-pretreated mice caused a highly significant increase in reaction time remaining above the control values for 3 h. This effect of morphine was antagonized by naloxone (2 mg/kg, s.c.). Captopril, when given together with morphine, prevented the increase in reaction time over 2 h, but caused a progressive and significant increase within 6 h. Morphine also prevented the jumping behaviour induced by captopril.
Aprotinin
(50,000 KIU/kg i.p.) when given together with captopril, produced a significant increase in reaction time but almost completely blocked the jumping reaction.
Aprotinin
also prevented the captopril-induced increase in the number of jumping mice. The possible mechanisms of
analgesia
and jumping behaviour due to thermal stimulation are discussed in the light of these findings.
...
PMID:Alterations by captopril of pain reactions due to thermal stimulation of the mouse foot: interactions with morphine, naloxone and aprotinin. 615 76
In this prospective, randomised, double-blind study, we investigated the effect of epidural anaesthesia and an antifibrinolytic agent,
Aprotinin
(500,000 KIU in bolus before surgery and 500,000 KIU h(-1) in drip form during surgery), on intra and postoperative blood loss and transfusion requirements in total hip arthroplasty. Sixty patients were allocated randomly to four groups (A: epidural + general anesthesia +
Aprotinin
, B: epidural + general anesthesia + placebo (equal volume), C: general anaesthesia +
Aprotinin
, D: general anaesthesia + placebo). Postoperative
analgesia
: epidural
analgesia
in groups A and B, systemic
analgesia
with opiates in groups C and D. Blood loss during surgery was monitored and salvaged with the Compact-A Dideco, and postoperative blood loss with the BT 797 Recovery Dideco for the first 24 hours. Perioperative blood loss, frequency and quantity of transfusions were significantly higher in group D (p<0.0001). Total blood loss was reduced by 31.3% by epidural anaesthesia, 20.4% by
Aprotinin
and 51.4% using a combination of the two techniques.
...
PMID:Reducing perioperative blood loss in patients undergoing total hip arthroplasty. 1009 85